The invention relates to a drug combination comprising 1:1-30:1 mass ratio blend of lecithin with 10.00-99.99 mass% L-alpha-phosphatidylcholine content and ascorbic acid which is suitable for the preservation and increase of the physical and cognitive performance of healthy and sick people.
